Published in J Infect Dis on November 11, 2002
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67
Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol (2010) 2.56
Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J Clin Microbiol (2008) 1.84
Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev (2010) 1.73
Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health. Clin Microbiol Rev (2009) 1.68
Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med (2008) 1.62
Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol (2011) 1.44
Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol (2011) 1.37
A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS One (2009) 1.34
Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR. J Clin Microbiol (2005) 1.28
Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J Clin Microbiol (2009) 1.27
Diverse characteristics of the CagA gene of Helicobacter pylori strains collected from patients from southern vietnam with gastric cancer and peptic ulcer. J Clin Microbiol (2009) 1.25
CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect (2009) 1.25
Pathogenesis of Helicobacter pylori-Related Gastroduodenal Diseases from Molecular Epidemiological Studies. Gastroenterol Res Pract (2012) 1.17
Distinct diversity of the cag pathogenicity island among Helicobacter pylori strains in Japan. J Clin Microbiol (2004) 1.12
Trend in gastric cancer: 35 years of surgical experience in Japan. World J Gastroenterol (2011) 1.05
Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol (2010) 1.02
A Tale of Two Toxins: Helicobacter Pylori CagA and VacA Modulate Host Pathways that Impact Disease. Front Microbiol (2010) 1.00
Heterogeneity in the activity of Mexican Helicobacter pylori strains in gastric epithelial cells and its association with diversity in the cagA gene. Infect Immun (2007) 0.99
Analysis of 3'-end variable region of the cagA gene in Helicobacter pylori isolated from Iranian population. J Gastroenterol Hepatol (2009) 0.97
Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases. J Res Med Sci (2012) 0.96
The cag PAI is intact and functional but HP0521 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore. Eur J Clin Microbiol Infect Dis (2010) 0.96
Analysis of the 3' variable region of the cagA gene of Helicobacter pylori isolated in Koreans. Dig Dis Sci (2007) 0.93
Helicobacter pylori cagA status and peptic ulcer disease in Iran. Dig Dis Sci (2008) 0.92
Variations in Helicobacter pylori cytotoxin-associated genes and their influence in progression to gastric cancer: implications for prevention. PLoS One (2012) 0.92
The enigma of Helicobacter pylori infection and gastric cancer. Indian J Gastroenterol (2010) 0.90
Assessment of risk factors of helicobacter pylori infection and peptic ulcer disease. J Glob Infect Dis (2013) 0.88
A specific A/T polymorphism in Western tyrosine phosphorylation B-motifs regulates Helicobacter pylori CagA epithelial cell interactions. PLoS Pathog (2015) 0.88
CagA and VacA polymorphisms do not correlate with severity of histopathological lesions in Helicobacter pylori-infected Greek children. J Clin Microbiol (2009) 0.88
Helicobacter pylori Diversity and Gastric Cancer Risk. MBio (2016) 0.88
Tyrosine phosphorylation of CagA from Chinese Helicobacter pylori isolates in AGS gastric epithelial cells. J Clin Microbiol (2005) 0.87
Characterization of CagA variable region of Helicobacter pylori isolates from Chinese patients. World J Gastroenterol (2005) 0.84
The Helicobacter pylori restriction endonuclease-replacing gene, hrgA, and clinical outcome: comparison of East Asia and Western countries. Dig Dis Sci (2004) 0.84
Identification of H. pylori strain specific DNA sequences between two clinical isolates from NUD and gastric ulcer by SSH. World J Gastroenterol (2003) 0.82
Virulence genes of Helicobacter pylori in the Dominican Republic. J Med Microbiol (2014) 0.81
Stability of randomly amplified polymorphic DNA fingerprinting in genotyping clinical isolates of Helicobacter pylori. World J Gastroenterol (2003) 0.80
Role of Helicobacter pylori CagA molecular variations in induction of host phenotypes with carcinogenic potential. J Infect Dis (2009) 0.80
Sequence analysis of East Asian cagA of Helicobacter pylori isolated from asymptomatic healthy Japanese and Thai individuals. Curr Microbiol (2010) 0.78
CagA EPIYA polymorphisms in Colombian Helicobacter pylori strains and their influence on disease-associated cellular responses. World J Gastrointest Oncol (2013) 0.76
Rare Helicobacter pylori Virulence Genotypes in Bhutan. Sci Rep (2016) 0.75
Surreptitious manipulation of the human host by Helicobacter pylori. Gut Microbes (2010) 0.75
Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc Jpn Acad Ser B Phys Biol Sci (2017) 0.75
Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A (2002) 3.50
Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis (2004) 1.78
Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology (2006) 1.77
Distinct diversity of vacA, cagA, and cagE genes of Helicobacter pylori associated with peptic ulcer in Japan. J Clin Microbiol (2005) 1.72
Transposable element ISHp608 of Helicobacter pylori: nonrandom geographic distribution, functional organization, and insertion specificity. J Bacteriol (2002) 1.60
Fulminant varicella infection complicated with acute respiratory distress syndrome, and disseminated intravascular coagulation in an immunocompetent young adult. Intern Med (2004) 1.54
Colonization dynamics of altered Schaedler flora is influenced by gender, aging, and Helicobacter hepaticus infection in the intestines of Swiss Webster mice. Appl Environ Microbiol (2006) 1.29
Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan. J Gastroenterol (2006) 1.16
The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis (2002) 1.13
Distinct diversity of the cag pathogenicity island among Helicobacter pylori strains in Japan. J Clin Microbiol (2004) 1.12
Intraductal mucinous tumors occurring simultaneously in the liver and pancreas. J Gastroenterol (2002) 1.05
Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'-C...G-3' stem structure. Cell Microbiol (2006) 1.03
The diversity of vacA and cagA genes of Helicobacter pylori in East Asia. FEMS Immunol Med Microbiol (2004) 1.00
Helicobacter pylori evolution: lineage- specific adaptations in homologs of eukaryotic Sel1-like genes. PLoS Comput Biol (2007) 0.99
Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET. Nucl Med Biol (2011) 0.96
A case of Gitelman syndrome associated with idiopathic intracranial hypertension. Intern Med (2011) 0.94
Hyperattenuating aortic wall on postmortem computed tomography (PMCT). Radiat Med (2002) 0.94
Hypoxia-inducible factor 1 alpha and vascular endothelial growth factor overexpression in ischemic colitis. World J Gastroenterol (2005) 0.93
Helicobacter pylori CagA containing ITAM-like sequences localized to lipid rafts negatively regulates VacA-induced signaling in vivo. Helicobacter (2003) 0.92
PET imaging of redox and energy states in stroke-like episodes of MELAS. Mitochondrion (2009) 0.90
Cytotoxic-T-lymphocyte-associated antigen 4 blockade abrogates protection by regulatory T cells in a mouse model of microbially induced innate immune-driven colitis. Infect Immun (2008) 0.89
Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images. Brain Dev (2009) 0.89
Evaluation of respiratory chain failure in mitochondrial cardiomyopathy by assessments of 99mTc-MIBI washout and 123I-BMIPP/99mTc-MIBI mismatch. Mitochondrion (2006) 0.89
Prion removal by nanofiltration under different experimental conditions. Biologicals (2007) 0.88
Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys (2006) 0.88
The casein kinase 2-nrf1 axis controls the clearance of ubiquitinated proteins by regulating proteasome gene expression. Mol Cell Biol (2013) 0.86
Meta-analysis of the relationship between CagA seropositivity and gastric cancer. Gastroenterology (2004) 0.85
Posterior reversible encephalopathy syndrome following measles vaccination. J Neurol Sci (2010) 0.85
[Cerebral venous thrombosis as a complication of nephrotic syndrome--a case report and literature review]. Rinsho Shinkeigaku (2014) 0.85
Novel reciprocal regulation of cAMP signaling and apoptosis by orphan G-protein-coupled receptor GPRC5A gene expression. Biochem Biophys Res Commun (2006) 0.84
Cytotoxicity and recognition of receptor-like protein tyrosine phosphatases, RPTPalpha and RPTPbeta, by Helicobacter pylori m2VacA. Cell Microbiol (2005) 0.84
Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial. J Gastroenterol (2012) 0.84
DNA sequencing and homologous expression of a small peptide conferring immunity to gassericin A, a circular bacteriocin produced by Lactobacillus gasseri LA39. Appl Environ Microbiol (2008) 0.84
Diversity of the cagA gene of Helicobacter pylori strains from patients with gastroduodenal diseases in the Philippines. FEMS Immunol Med Microbiol (2010) 0.83
Muscle MRI findings of HTLV-1-associated myelopathy. J Neurol Sci (2002) 0.82
Pitavastatin decreases tau levels via the inactivation of Rho/ROCK. Neurobiol Aging (2011) 0.82
Clinical relevance of cagE gene from Helicobacter pylori strains in Japan. Dig Dis Sci (2002) 0.82
[Case of oromandibular dystonia presenting with severe impairment of mouth-opening, and a marked effect by administration of baclofen]. Rinsho Shinkeigaku (2006) 0.82
Helicobacter pylori-dependent NF-kappa B activation in newly established Mongolian gerbil gastric cancer cell lines. Cancer Sci (2005) 0.81
A case of Helicobacter pylori-negative intramucosal well-differentiated gastric adenocarcinoma with intestinal phenotype. Clin J Gastroenterol (2015) 0.81
Leg ulcer caused by Mycobacterium ulcerans ssp. shinshuense infection. Int J Dermatol (2009) 0.81
[A steroid-responsive case of severe rhabdomyolysis associated with cytomegalovirus infection]. Rinsho Shinkeigaku (2006) 0.81
Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): adverse effects and eecommended dose of NDP administered after 5-FU. Am J Clin Oncol (2002) 0.81
Identification of Helicobacter pylori and the cagA genotype in gastric biopsies using highly sensitive real-time PCR as a new diagnostic tool. FEMS Immunol Med Microbiol (2005) 0.81
Hym-301, a novel peptide, regulates the number of tentacles formed in hydra. Development (2005) 0.81
Posterior reversible encephalopathy syndrome of the midbrain and hypothalamus - a case report of uremic encephalopathy presenting with hypersomnia. Rinsho Shinkeigaku (2015) 0.80
Treatment outcomes of definitive chemoradiotherapy for patients with hypopharyngeal cancer. J Radiat Res (2012) 0.80
Factors responsible for long-term survival in metastatic breast cancer. World J Surg Oncol (2014) 0.80
Analysis of the shape of the tibial tray in total knee arthroplasty using a three dimension finite element model. Clin Biomech (Bristol, Avon) (2002) 0.80
[Paraneoplastic retinopathy and optic neuropathy]. Brain Nerve (2010) 0.80
[Case of neuro-Behçet disease with HLA-B54, Cw1, which is difficult in clinical diagnosis from neuro-Sweet disease]. Rinsho Shinkeigaku (2009) 0.80
Hashimoto's encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration. Eur Neurol (2012) 0.79
ThyA as a selection marker in construction of food-grade host-vector and integration systems for Streptococcus thermophilus. Appl Environ Microbiol (2004) 0.79
Muscle MRI in myotonic dystrophy type 1 with foot drop. Eur Neurol (2010) 0.79
[Effects of voriconazole and vascular lesions in invasion of aspergillosis into the central nerve system]. Rinsho Shinkeigaku (2009) 0.79
Clinical usefulness of human epidermal growth factor receptor-2 extracellular domain as a biomarker for monitoring cancer status and predicting the therapeutic efficacy in breast cancer. Cancer Biol Ther (2012) 0.78
Abnormal intracellular trafficking of high affinity nerve growth factor receptor, Trk, in stable transfectants expressing presenilin 1 protein. Brain Res Mol Brain Res (2005) 0.78
Acute encephalomyelitis associated with acute viral hepatitis type B. Intern Med (2009) 0.78
Effects of percutaneous endoscopic gastrostomy tube placement on gastric antral motility and gastric emptying. J Gastroenterol (2003) 0.77
Gastric dysmotility associated with accumulation of mitochondrial A3243G mutation in the stomach. Intern Med (2004) 0.77
Evaluation of systemic redox states in patients carrying the MELAS A3243G mutation in mitochondrial DNA. Eur Neurol (2012) 0.77